- Home
- CXM vs IMTX Comparison
CXM vs IMTX Comparison
Compare CXM & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CXM | IMTX |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CXM | IMTX |
|---|---|---|
| Price | $5.30 | $8.26 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | $8.28 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 3.5M | 540.4K |
| Earning Date | 06-03-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $857,200,000.00 | N/A |
| Revenue This Year | $2.52 | N/A |
| Revenue Next Year | $4.94 | $25.91 |
| P/E Ratio | $108.60 | ★ N/A |
| Revenue Growth | ★ 7.64 | N/A |
| 52 Week Low | $4.72 | $7.10 |
| 52 Week High | $8.28 | $12.41 |
Technical Indicators
Market Signals| Indicator | CXM | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 37.12 | 40.04 |
| Support Level | $5.18 | $8.36 |
| Resistance Level | $5.60 | $10.51 |
| Average True Range (ATR) | 0.21 | 0.30 |
| MACD | -0.06 | -0.03 |
| Stochastic Oscillator | 26.32 | 14.98 |
Price Performance
Historical ComparisonAbout CXM Sprinklr Inc.
Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale, all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights, and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.